HAL vs NAGE · P/E 9.3, $19.05B cap vs P/E 59, rev $99.6M
Halliburton Company (HAL) versus Niagen Bioscience, Inc. (NAGE) — a side-by-side from cached financials, not a winner call.
Halliburton Company (HAL) is a oil & gas equipment & services company listed on US.
Niagen Bioscience, Inc. (NAGE) is a biotechnology company listed on US.
HAL does not have a complete income-statement cache yet.
Latest reported NAGE revenue for 2024-12-31 was $99.6M. Net income was $8.6M. Revenue was up 19.2% from 2023-12-31 to 2024-12-31. NAGE currently screens at market cap $836.5M and trailing P/E 59.0.
HAL currently screens at market cap $19.05B and trailing P/E 9.3. NAGE currently screens at market cap $836.5M and trailing P/E 59.0.
Not investment advice. Open the HAL and NAGE stock pages for the full models.
Not investment advice.